Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter phase II study of palonosetron + dexamethasone for prevention of chemotherapy-induced nausea and vomiting in resected colon cancer
2006-002935-25Phase 2Active
- Sponsor
- GOIM
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by GOIM. Started Jul 2007; status: active.
02
Drugs
palonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on 2006-002935-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002935-25.